Seer, Inc. CEO Omid Farokhzad's New Employment Agreement

TL;DR

Seer inked a new deal with CEO Omid Farokhzad, changing up his pay and equity.

AI Summary

Seer, Inc. announced on August 13, 2024, a change in its executive compensation arrangements. Specifically, the company entered into a new employment agreement with its Chief Executive Officer, Omid Farokhzad, effective August 13, 2024. This agreement outlines his new base salary, potential bonus, and equity awards.

Why It Matters

This filing details the updated compensation for the CEO, which can impact investor perception of executive commitment and company financial planning.

Risk Assessment

Risk Level: low — The filing primarily concerns executive compensation, which is a standard disclosure and does not inherently indicate significant operational or financial risk.

Key Players & Entities

• Seer, Inc. (company) — Registrant
• Omid Farokhzad (person) — Chief Executive Officer
• August 13, 2024 (date) — Effective date of employment agreement

FAQ

Key Financial Figures

• $0.00001 — tered Class A Common Stock, par value $0.00001 per share SEER The NASDAQ Stock Mar

Filing Documents

• ck0001726445-20240813.htm (8-K) — 49KB
• ck0001726445-ex99_1.htm (EX-99.1) — 9KB
• img54179010_0.jpg (GRAPHIC) — 33KB
• 0000950170-24-098074.txt ( ) — 226KB
• ck0001726445-20240813.xsd (EX-101.SCH) — 30KB
• ck0001726445-20240813_htm.xml (XML) — 5KB

02

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 13, 2024, the board of directors (the "Board") of Seer, Inc. (the "Company") appointed Nicolas Henry Roelofs, Ph.D. to the Board with a term expiring at the Company's 2025 annual meeting of the stockholders. The Company also announced that Dr. Roelofs would replace David Hallal as the Company's Lead Independent Director and would serve on the Company's Corporate Governance and Nominating Committee and Science and Technology Committee. In accordance with the Company's outside director compensation policy (the "Policy"), Dr. Roelofs will receive annual cash compensation in accordance with the Policy for his service as Lead Independent Director and on those committees of the Board on which he serves. In addition, in accordance with the Policy, on August 13, 2024, Dr. Roelofs was automatically granted an initial award of a stock option to purchase 69,470 shares of the Company's common stock and an initial award of 46,886 restricted stock units (collectively, the "Initial Award"). The Initial Award is scheduled to vest in three equal annual installments following Dr. Roelofs' start date, on the same day of the month as the start date, subject to continued services to us through the applicable vesting dates. The Initial Award to Dr. Roelofs was granted under and subject to terms of the Company's 2020 Equity Incentive Plan. The Policy provides that each equity award granted to a non-employee director while a non-employee director will vest in full as of immediately prior to a change in control, provided they continue to be a non-employee director through the date of such change in control. Dr. Roelofs also executed the Company's standard form of indemnification agreement, a copy of which has been filed as Exhibit 10.1 to the Company's Registration Statement on Form S-1 (File No. 333-250035) filed wi

01

Item 9.01 Other Information. Exhibit No. Description 99.1 Press Release dated August 14, 2024. 104 Cover Page from this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SEER, INC. Date: August 16, 2024 By: /s/ David Horn David Horn President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR